EXECUTIVE ENGAGEMENTS
OUTREACH
823
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
163
Interactions with Platform & by Email
PARTICIPANTS
33
Unique # Participated
VALIDATIONS
16
Responses Validated*
COMPETITORS
42
Responses Validated*
BRANDS
5
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
105
PAGES
177
EDITION
9
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Biological Safety Cabinets estimated at US$161.6 Million in the year 2020, is projected to reach a revised size of US$242.5 Million by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Class I, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$84.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Class II segment is readjusted to a revised 6.5% CAGR for the next 7-year period.
The Biological Safety Cabinets market in the U.S. is estimated at US$47.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$42.7 Million by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
In the global Class III segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$32 Million in the year 2020 will reach a projected size of US$46.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$27.9 Million by the year 2027.
SELECT PLAYERS
Air Science LLC; Berner International; BIOBASE; Cruma - Diantech Solutions S.L.; Esco Micro Pte. Ltd.; Euroclone S.p.A.; Germfree; Kewaunee Scientific Corporation; Labconco Corporaton; NuAire, Inc.; The Baker Company, Inc.; Thermo Fisher Scientific, Inc.
SEGMENTS
» End-Use (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) » Type (Class I, Class II, Class III)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Biological Safety Cabinet to Register Steady Growth |
| Class II Biological Safety Cabinets to Account for Highest Growth, Driven by Higher Level of Protection |
| Table: A Brief Description of Class I, Class II, and Class III Biological Safety Cabinets |
| By End-User Segment, Pharmaceutical & Biopharmaceutical Companies to Register Largest Growth |
| Table: Market Share of Biological Safety Cabinet by End-User Type |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Emergence of Various Communicable Diseases to Bode Well for Market Demand |
| Table: Breakdown of Total Number of Diseases Reported by Disease Variety: 1980 to 2010 |
| Table: Total Number of Disease Cases from Fleas, Ticks, and Mosquitoes in the US: 2004 to 2016 |
| Innovations to Support Market Growth |
| Spur in R&D Activities to Bode Well for Market Growth |
| Table: Total Worldwide Spending (in Billion USD) on Pharmaceutical R&D: 2010 to 2024 |
| Availability of Alternatives to Biological Safety Cabinets to Deter Market Growth |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biological Safety Cabinets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Class I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Class I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Class II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Class II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Class III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Class III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Diagnostic & Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Diagnostic & Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Research Institution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Research Institution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biological Safety Cabinets by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biological Safety Cabinets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Biological Safety Cabinets by Type - Class I, Class II and Class III - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biological Safety Cabinets by Type - Class I, Class II and Class III Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biological Safety Cabinets by Type - Percentage Breakdown of Value Sales for Class I, Class II and Class III for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biological Safety Cabinets by End-Use - Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biological Safety Cabinets by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories and Academic & Research Institution for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
The World of Biological Safety Cabinets is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com